Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The role of cysteine residues in glucose-transporter-GLUT1-mediated transport and transport inhibition.
Wellner M
,
Monden I
,
Keller K
.
???displayArticle.abstract???
The role of cysteine residues in transport function of the glucose transporter GLUT1 was investigated by a mutagenesis-expression strategy. Each of the six cysteine residues was individually replaced by site-directed mutagenesis. Expression of the heterologous wild-type or mutant glucose transporters and transport measurements at two hexose concentrations (50 microM and 5 mM) were undertaken in Xenopus oocytes. The catalytic activity of GLUT1 was retained, despite substitution of each single cysteine residue, which indicated that no individual residue is essential for hexose transport. This finding questions the involvement of oligomerization or intramolecular stabilization by a single disulphide bond as a prerequisite for transporter activation under basal conditions. Application of the impermeant mercurial thiol-group-reactive reagent p-chloromercuribenzenesulphonate (pCMBS) to the external or internal surface of plasma membrane demonstrated that cysteine-429, within the sixth external loop, and cysteine-207, at the beginning of the large intracellular loop which connects transmembrane segments 6 and 7, are the residues which are involved in transport inhibition by impermeant thiol-group-reactive reagents from either side of the cell. These data support the predicted membrane topology of the transport protein by transport measurements. If residues other than the cysteines at positions 429 or 207 are exposed to either side of the plasma membrane by conformational changes, they do not contribute to the transport inhibition by pCMBS. Application of pCMBS to one side of the plasma membrane also inhibited transport from the opposite direction, most likely due to the hindrance of sugar-induced interconversion of transporter conformation.
Asano,
The role of N-glycosylation of GLUT1 for glucose transport activity.
1991, Pubmed
Asano,
The role of N-glycosylation of GLUT1 for glucose transport activity.
1991,
Pubmed
Baldwin,
Probing the structure and function of the human erythrocyte glucose transporter.
1992,
Pubmed
Batt,
Impermeant maleimides. Identification of an exofacial component of the human erythrocyte hexose transport mechanism.
1976,
Pubmed
Bell,
Molecular biology of mammalian glucose transporters.
1990,
Pubmed
Burant,
Fructose transporter in human spermatozoa and small intestine is GLUT5.
1992,
Pubmed
,
Xenbase
Burant,
Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins.
1992,
Pubmed
,
Xenbase
Carruthers,
Facilitated diffusion of glucose.
1990,
Pubmed
Deziel,
The topology of the major band 4.5 protein component of the human erythrocyte membrane: characterization of reactive cysteine residues.
1985,
Pubmed
Garcia,
Amino acid substitutions at tryptophan 388 and tryptophan 412 of the HepG2 (Glut1) glucose transporter inhibit transport activity and targeting to the plasma membrane in Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Gould,
Facilitative glucose transporters: an expanding family.
1990,
Pubmed
Gould,
The glucose transporter family: structure, function and tissue-specific expression.
1993,
Pubmed
Hashiramoto,
Site-directed mutagenesis of GLUT1 in helix 7 residue 282 results in perturbation of exofacial ligand binding.
1992,
Pubmed
Hebert,
Glucose transporter oligomeric structure determines transporter function. Reversible redox-dependent interconversions of tetrameric and dimeric GLUT1.
1992,
Pubmed
Holman,
Photolabelling of the hexose transporter at external and internal sites: fragmentation patterns and evidence for a conformational change.
1987,
Pubmed
Ishihara,
The glucose transport activity of GLUT1 is markedly decreased by substitution of a single amino acid with a different charge at residue 415.
1991,
Pubmed
Katagiri,
Substitution of leucine for tryptophan 412 does not abolish cytochalasin B labeling but markedly decreases the intrinsic activity of GLUT1 glucose transporter.
1991,
Pubmed
Keller,
Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters.
1989,
Pubmed
,
Xenbase
Keller,
Different mammalian facilitative glucose transporters expressed in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
King,
Cytochalasin B interferes with conformational changes of the human erythrocyte glucose transporter induced by internal and external sugar binding.
1991,
Pubmed
Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase
Krupka,
Reaction of the glucose carrier of erythrocytes with sodium tetrathionate: evidence for inward-facing and outward-facing carrier conformations.
1985,
Pubmed
Kunkel,
Rapid and efficient site-specific mutagenesis without phenotypic selection.
1987,
Pubmed
May,
Monitoring conformational change in the human erythrocyte glucose carrier: use of a fluorescent probe attached to an exofacial carrier sulfhydryl.
1993,
Pubmed
Mueckler,
Sequence and structure of a human glucose transporter.
1985,
Pubmed
Mueckler,
The human glucose transporter can insert posttranslationally into microsomes.
1986,
Pubmed
Pessino,
Evidence that functional erythrocyte-type glucose transporters are oligomers.
1991,
Pubmed
Rampal,
Substrate-induced conformational change of human erythrocyte glucose transporter: inactivation by alkylating reagents.
1987,
Pubmed
Silverman,
Structure and function of hexose transporters.
1991,
Pubmed
Walmsley,
The dynamics of the glucose transporter.
1988,
Pubmed
Wellner,
The differential role of Cys-421 and Cys-429 of the Glut1 glucose transporter in transport inhibition by p-chloromercuribenzenesulfonic acid (pCMBS) or cytochalasin B (CB).
1992,
Pubmed
,
Xenbase
